The Indian government has banned oral Nimesulide formulations above 100mg, including tablets and syrups, citing serious liver safety concerns.
CRISPR became big in 2025, bringing advances for serious Indian health risks, which will continue in the coming year
The year 2025 has been a significant one for the Indian pharmaceutical sector. It witnessed several novel launches, collaborations, digital…
Novo Nordisk’s US medical lead, Dr Jason Brett, told CNN that the pill is expected to give patients more choices…
The class of GLP-1 agonist medications act by lowering the appetite with applications way beyond diabetes. These medicines will be…
Novo Nordisk has launched its blockbuster diabetes drug Ozempic in India, pricing the starter dose at ₹8,800 per month (₹2,200…
Nutrition experts noted that people are increasingly recognising the links between gut health, hormones, blood sugar balance and overall wellbeing.
According to the foundation, its healthcare operations currently span 143 projects across 22 states and 90 districts, including 22 Aspirational…
The India Reimagined Fellowship promises Rs 2.5 crore per fellow for 3 years to fuel India’s health future
Despite herd immunity for HPV in the West, it is necessary to be vaccinated.
A new HCL Healthcare study reveals an alarming mental health crisis in the Indian corporate sector, with 84% of employees…
After months of hearings, the Delhi High Court delivered the landmark ruling which cleared the way for Natco Pharma to…
A new EY-Parthenon report forecasts India’s healthcare expenditure will skyrocket 17-fold to Rs 190 lakh crore by 2047, driven by…
India’s drug regulator, CDSCO, found serious failures in mandatory batch testing at drug facilities and issued an advisory to state…
The development came even as the Tamil Nadu government initiated criminal action against a pharmaceutical company for sale of adulterated…
The deal, executed through Indegene’s subsidiary ILSL Inc., aims to strengthen Indegene’s commercialisation portfolio and expand its AI-powered marketing and…
AI is finding its way into the practice of cardiology, not as a replacement for the doctor, but as a…
Genomic firms have started offering tailored localised test at low cost.